Development

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Articles

Particle engineering is a useful tool to manipulate API particles into a form that is manufacturable and deliverable to the patient.

A Great Manipulation: The Value of Engineering Particle Properties

Kindeva Drug Delivery plans capital investment and jobs growth.

Former 3M Drug Delivery Systems Launches as Kindeva Drug Delivery

The new molecules entering the development pipeline are bringing forth exciting challenges in drug delivery.

Delivering the Goods

Synairgen, a respiratory drug discovery and development company, has announced that it has received expedited approvals to conduct a trial of its inhaled formulation of interferon-beta-1a, SNG001, in COVID-19 patients.


UK Company Starts Trials of Inhaled Formulation for COVID-19

Perrigo will be producing a limited amount of the generic inhaler medication but will accelerate production to meet future demands in collaboration with Catalent. 

Catalent and Perrigo Announce Approval of Generic Version of Teva Inhaler Med

Research compared the properties of corticosteroids processed by wet and dry milling for use in inhalation formulations.

Inhalation Drug Delivery: The Impact of Particle Size Reduction

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

A connected MDI may encourage compliance and aid proper technique.

Considering Connected Inhalation Drug Delivery

Consider both the device characteristics and the powder properties when developing a DPI combination product.

Best Practices for Developing Dry Powder Inhaler Combination Drug-Device Products

Hovione Technology has acquired global rights to a dry powder inhaler for pulmonary drug delivery, the Papillon DPI invented by Dr. Klaus-Dieter Beller.

Hovione Technology Acquires Rights to New Blister-Based Inhaler

3M Drug Delivery Systems UK organization has revealed that it is relocating its R&D team to the Charnwood Campus, which is an officially designated Life Sciences Opportunity Zone in Loughborough, United Kingdom

Formulation and Drug Delivery, Inhalation Drugs